Chinese Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2024-03-25 ms4000000320228007 来自湖北省

版面费怎么收？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-03-29 smuytj 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：中药药理学
经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-10-30 ms6000000450980482 来自天津

想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展

30 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-04-10 ms1000001779792578 来自山东省

请问reviewers assigned 大约多久会有状态变化啊？已经两周了

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-03-31 ms1000000482995796 来自北京

审稿速度:1.0
偏重的研究方向：中医
经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-04-04 ms7000000307422374 来自福建省

这个杂志要实验吗

72 0

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2023-03-24 ms8000000576785230 来自广东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：非酒精性脂肪肝;中药药效
经验分享：暂无

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2022-05-03 ms5000001271611106

请问这个杂志需要原始数据吗，还是只要原图就行？

90 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2022-11-07 ms5000001761757413

请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用

78 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122573, encodeId=4ea721225e384, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药药理学 经验分享：请问大家有通过invoice的方式付版面费吗？在导师邮件里面点击链接后，没有给我发invoice是什么情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f05538936, createdName=smuytj, createdTime=Wed Mar 29 22:18:54 CST 2023, time=2023-03-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2124868, encodeId=abe821248680b, content=请问reviewers assigned 大约多久会有状态变化啊？已经两周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66b8523560, createdName=ms1000001779792578, createdTime=Mon Apr 10 18:57:03 CST 2023, time=2023-04-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2122884, encodeId=05ef2122884c8, content=审稿速度:1.0 偏重的研究方向：中医 经验分享：请问各位主任大佬，大修修回会经过under review吗？revision submitted 一个多月了是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab55699496, createdName=ms1000000482995796, createdTime=Fri Mar 31 07:20:51 CST 2023, time=2023-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123733, encodeId=38492123e3343, content=这个杂志要实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Tue Apr 04 20:17:33 CST 2023, time=2023-04-04, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2121586, encodeId=a6ac21215867b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：非酒精性脂肪肝;中药药效 经验分享：暂无 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16e6568851, createdName=ms8000000576785230, createdTime=Fri Mar 24 15:04:32 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226400, encodeId=13d5122640041, content=各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb08099057, createdName=ms6000001771647239, createdTime=Tue Jun 14 15:27:43 CST 2022, time=2022-06-14, status=1, ipAttribution=)]

2022-06-14 ms6000001771647239

各位同行朋友们，请问一下，五月底投了这个杂志，到现在还是editor assigned 的状态，这可能是什么原因呢？这种情况可以催一下吗？

88 18

展开18条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务